Emergency-use authorization of peramivir.
Gonzalez
Richard
R
Massoomi
Firouzan
F
Neff
William
W
D000146:Acids, Carbocyclic; D000328:Adult; D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002487:Centers for Disease Control and Prevention, U.S.; D002648:Child; D017322:Clinical Trials, Phase II as Topic; D017326:Clinical Trials, Phase III as Topic; D003422:Critical Care; D003517:Cyclopentanes / Q000009:adverse effects / Q000627:therapeutic use*; D015507:Drugs, Investigational; D004632:Emergency Medical Services; D006146:Guanidines / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype; D007251:Influenza, Human / Q000188:drug therapy*; D014481:United States
D000146:Acids, Carbocyclic; D000998:Antiviral Agents; D003517:Cyclopentanes; D015507:Drugs, Investigational; D006146:Guanidines; C414210:peramivir